Britton, Warwick - University of Sydney

研究领域

Professor Britton is the Head of the Discipline of Infectious Diseases & Immunology and the Mycobacterial Research Program in the Centenary Institute of Cancer Medicine & Cell Biology, where he studies the immunological control of tuberculosis and new vaccine strategies to control this major human infection.

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Ritz, N., Casalaz, D., Donath, S., Tebruegge, M., Dutta, B., Connell, T., Robins-Browne, R., Britton, W., Hanekom, W., Curtis, N. (2016). Comparable CD4 and CD8 T cell responses and cytokine release after at birth and delayed BCG immunisation in infants born in Australia. Vaccine, 34(35), 4132-4139. [More Information] Parumasivam, T., Chang, R., Abdelghany, S., Ye, T., Britton, W., Chan, K. (2016). Dry powder inhalable formulations for anti-tubercular therapy. Advanced Drug Delivery Reviews, 102, 83-101. [More Information] Stifter, S., Bhattacharyya, N., Pillay, R., Florido, M., Triccas, J., Britton, W., Feng, C. (2016). Functional Interplay between Type I and II Interferons Is Essential to Limit Influenza A Virus-Induced Tissue Inflammation. PLoS Pathogens, 12(1), 1-20. [More Information] Parumasivam, T., Chan, J., Pang, A., Quan, D., Triccas, J., Britton, W., Chan, K. (2016). In Vitro Evaluation of Inhalable Verapamil-Rifapentine Particles for Tuberculosis Therapy. Molecular Pharmaceutics, 13(3), 979-989. [More Information] Parumasivam, T., Chan, J., Pang, A., Quan, D., Triccas, J., Britton, W., Chan, K. (2016). In vitro evaluation of novel inhalable dry powders consisting of thioridazine and rifapentine for rapid tuberculosis treatment. European Journal of Pharmaceutics and Biopharmaceutics, 107, 205-214. [More Information] Pinto (Pinto-Nadanachandran), R., Nambiar, J., Leotta, L., Counoupas, C., Britton, W., Triccas, J. (2016). Influence of phthiocerol dimycocerosate on CD4�?� T cell priming and persistence during Mycobacterium tuberculosis infection. Tuberculosis, 99, 25-30. [More Information] Leung, S., Parumasivam, T., Gao, F., Carrigy, N., Vehring, R., Finlay, W., Morales, S., Britton, W., Kutter, E., Chan, K. (2016). Production of Inhalation Phage Powders Using Spray Freeze Drying and Spray Drying Techniques for Treatment of Respiratory Infections. Pharmaceutical Research, 33(6), 1486-1496. [More Information] Parumasivam, T., Leung, S., Quan, D., Triccas, J., Britton, W., Chan, K. (2016). Rifapentine-loaded PLGA microparticles for tuberculosis inhaled therapy: Preparation and in vitro aerosol characterization. European Journal of Pharmaceutical Sciences, 88, 1-11. [More Information] Giltrap, A., Dowman, L., Nagalingam, G., Ochoa, J., Linington, R., Britton, W., Payne, R. (2016). Total synthesis of teixobactin. Organic Letters, 18(11), 2788-2791. [More Information] Fox, G., Loan, L., Viet Nhung, N., Loi, N., Sy, D., Britton, W., Marks, G. (2015). Barriers to adherence with tuberculosis contact investigation in six provinces of Vietnam: a nested case-control study. BMC Infectious Diseases, 15(1), 1-8. [More Information] Florido, M., Pillay, R., Gillis, C., Xia, Y., Turner, S., Triccas, J., Stambas, J., Britton, W. (2015). Epitope-specific CD4(+) , but not CD8(+) , T-cell responses induced by recombinant influenza A viruses protect against Mycobacterium tuberculosis infection. European Journal of Immunology, 45(3), 780-793. [More Information] Barry, S., Chan, B., Ellis, M., Yang, Y., Plit, M., Guan, G., Wang, X., Britton, W., Saunders, B. (2015). Identification of miR-93 as a suitable miR for normalizing miRNA in plasma of tuberculosis patients. Journal of Cellular and Molecular Medicine, 19(7), 1606-1613. [More Information] Hare, N., Chan, B., Chan, E., Kaufman (nee Alexander), K., Britton, W., Saunders, B. (2015). Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15. Proteomics, 15(17), 3020-3029. [More Information] Chan, J., Tyne, A., Pang, A., McLachlan, A., Perera, V., Chan, J., Britton, W., Chan, K., Duke, C., Young, P., Traini, D. (2015). Murine pharmacokinetics of rifapentine delivered as an inhalable dry powder. International Journal of Antimicrobial Agents, 45(3), 319-323. [More Information] Chan, J., Duke, C., Ong, H., Chan, J., Tyne, A., Chan, H., Britton, W., Young, P., Traini, D. (2014). A Novel Inhalable Form of Rifapentine. Journal of Pharmaceutical Sciences, 103(5), 1141-1421. [More Information] Chan, J., Tyne, A., Pang, A., Chan, H., Young, P., Britton, W., Duke, C., Traini, D. (2014). A Rifapentine-Containing Inhaled Triple Antibiotic Formulation for Rapid Treatment of Tubercular Infection. Pharmaceutical Research, 31(5), 1239-1253. [More Information] Weber-Chrysochoou, C., Crisafulli, D., Kemp, A., Britton, W., Marks, G., Investigators, C. (2014). Allergen-specific IL-5 responses in early childhood predict asthma at age eight. PloS One, 9(5), 1-7. [More Information] Majumdar, S., Marais, B., Denholm, J., Britton, W. (2014). Drug-resistant tuberculosis: collaborative regional leadership required. Medical Journal of Australia, 200(5), 241-242. [More Information] Fox, G., Sy, D., Viet Nhung, N., Yu, B., Ellis, M., Hung, N., Cuong, N., Lien, L., Marks, G., Saunders, B., Britton, W. (2014). Polymorphisms of SP110 Are Associated with both Pulmonary and Extra-Pulmonary Tuberculosis among the Vietnamese. PloS One, 9(7), e99496. [More Information] Gunaratnam, P., Britton, W., Hofmeyr, A. (2013). Bug breakfast in the bulletin: Leprosy. NSW Public Health Bulletin, 24(1), 50-50.